Free Trial
NASDAQ:PVLA

Palvella Therapeutics (PVLA) Stock Price, News & Analysis

$13.09 +0.11 (+0.85%)
As of 10:32 AM Eastern

About Palvella Therapeutics Stock (NASDAQ:PVLA)

Key Stats

Today's Range
$12.55
$13.18
50-Day Range
N/A
52-Week Range
$6.20
$22.32
Volume
3,809 shs
Average Volume
48,722 shs
Market Capitalization
$17.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$38.00
Consensus Rating
Buy

Company Overview

Palvella Therapeutics Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
49th Percentile Overall Score

PVLA MarketRank™: 

Palvella Therapeutics scored higher than 49% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Palvella Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Palvella Therapeutics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Palvella Therapeutics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Palvella Therapeutics is -1.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for PVLA.
  • Dividend Yield

    Palvella Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Palvella Therapeutics does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for PVLA.
  • News Sentiment

    Palvella Therapeutics has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.06 average news sentiment score of companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Palvella Therapeutics this week, compared to 3 articles on an average week.
  • Search Interest

    6 people have searched for PVLA on MarketBeat in the last 30 days.
  • MarketBeat Follows

    4 people have added Palvella Therapeutics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Palvella Therapeutics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $51,720.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 6.39% of the stock of Palvella Therapeutics is held by insiders.

  • Percentage Held by Institutions

    40.11% of the stock of Palvella Therapeutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Palvella Therapeutics' insider trading history.
Receive PVLA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PVLA Stock News Headlines

Palvella Therapeutics, Inc. (PVLA)
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Palvella Therapeutics (NASDAQ:PVLA) Given Buy Rating at HC Wainwright
Palvella Therapeutics announces results from Phase 2 study of QTORIN
See More Headlines

PVLA Stock Analysis - Frequently Asked Questions

Palvella Therapeutics' stock was trading at $12.00 at the start of the year. Since then, PVLA shares have increased by 10.8% and is now trading at $13.30.
View the best growth stocks for 2025 here
.

Shares of PVLA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:PVLA
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$38.00
High Stock Price Target
$38.00
Low Stock Price Target
$38.00
Potential Upside/Downside
+185.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$17.56 million
Optionable
N/A
Beta
0.67
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:PVLA) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners